Robinul Glycopyrrolate Tablets 1mg

Brand-name Robinul tablets containing 1mg glycopyrrolate bromide for treating peptic ulcers and reducing gastric secretions. This retail-packed medicament primarily affects the digestive system, fitting HTS 3004.90.92.57. Put up in measured doses as solid oral forms.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFreeFree
🇲🇽MexicoFreeFree
🇨🇦CanadaFreeFree
🇩🇪GermanyFreeFree
🇯🇵JapanFreeFree

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3004.90Same rate: Free

If primarily affecting 5-HT receptors

Other digestive medicaments have separate subheadings based on mechanism.

2939Higher: 16.5% vs Free

If imported as pure chemical intermediate

Organic chemicals of incomplete molecules classify outside medicaments chapter.

3002.90Higher: 10% vs Free

If immunological product like antibody conjugate

Chapter notes define 3002 for immunologicals, excluding standard anticholinergics.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

Submit NDC numbers and Orange Book listings for FDA verification

Label with lot numbers, expiry dates, and child-resistant packaging requirements

Watch for transshipment rules; direct sourcing reduces scrutiny on authenticity

Related Products under HTS 3004.90.92.57

Glycopyrrolate Oral Solution 1mg/5mL

This is a liquid oral medication containing glycopyrrolate, an anticholinergic agent used to reduce saliva production in patients undergoing surgery or with chronic drooling conditions. It falls under HTS 3004.90.92.57 as a medicament primarily affecting the digestive system, put up in measured doses for therapeutic use. The product is mixed with water or other solvents but classified as unmixed per chapter notes.

Glycopyrrolate Injection 0.2mg/mL Vial

Sterile injectable solution of glycopyrrolate used preoperatively to inhibit salivary secretions and block cardiac vagal activity. Classified under HTS 3004.90.92.57 for medicaments affecting the digestive system in measured doses. It is an unmixed product per chapter notes despite solvent dissolution.

Glycopyrrolate Nasal Spray 0.5mg/dose

Metered-dose nasal spray formulation of glycopyrrolate for sialorrhea treatment in neurological disorders, targeting salivary glands linked to digestive function. HTS 3004.90.92.57 applies as a mixed product in measured doses for therapeutic use on digestive system.

Cuvposa Glycopyrrolate Oral Solution

Prescription Cuvposa brand oral solution with glycopyrrolate for chronic severe drooling in pediatric cerebral palsy patients. Affects digestive-related secretions; classified in HTS 3004.90.92.57 for measured-dose medicaments primarily for digestive system.

Generic Glycopyrrolate Bromide 2mg/mL Injection

Generic sterile injectable glycopyrrolate bromide used intraoperatively to dry secretions and prevent bradycardia. HTS 3004.90.92.57 covers this digestive-affecting medicament in pre-filled syringes or vials for measured administration.

Glycopyrrolate 0.4mg/mL IV Premix Bag

Ready-to-use IV premix bag containing glycopyrrolate for hospital administration to control gastric motility. As a dissolved unmixed product per notes, in measured doses for digestive therapeutic uses under HTS 3004.90.92.57.